WebSage Therapeutics, Inc. , a biopharmaceutical company leading the way to create a world with better brain health, today announced the appointment of Jessica Federer to the … WebApr 13, 2024 · The goal of this activity is for learners to increase their knowledge regarding limitations of current classes of antidepressant treatments used to manage major depressive disorder (MDD), and to increase their awareness of novel antidepressant mechanisms and related clinical trial outcomes. Upon completion of this activity, …
Brad Herskowitz, MD - Dr. Brad J. Herskowitz, Miami Neurologist
WebSep 16, 2014 · September 16, 2014 by Talent4Boards Team. – USA, MA – SAGE Therapeutics (Nasdaq:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced the appointment of Michael F. Cola to the company’s board of directors. WebMar 16, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced the appointment of Jessica Federer to the company’s Board of Directors.“We are thrilled to have Jessica join our Board of Directors. Jessica is a … bebe eliminar gases
Corporate Governance - Sage Therapeutics
Web1 day ago · Sage Therapeutics, Inc. (SAGE) Soars 9.6%: Is Further Upside Left in the Stock? ... Sage Therapeutics Appoints Jessica Federer to Board of Directors 03/16/23-6:30AM EST Business Wire WebStockholders who wish to communicate directly with our Board of Directors, or any individual director, should direct questions in writing to the address provided below. … WebMar 16, 2024 · CAMBRIDGE, Mass., March 16, 2024--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain … bebe email